DK1454992T3 - Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf - Google Patents

Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf

Info

Publication number
DK1454992T3
DK1454992T3 DK03005186T DK03005186T DK1454992T3 DK 1454992 T3 DK1454992 T3 DK 1454992T3 DK 03005186 T DK03005186 T DK 03005186T DK 03005186 T DK03005186 T DK 03005186T DK 1454992 T3 DK1454992 T3 DK 1454992T3
Authority
DK
Denmark
Prior art keywords
reagents
compositions
kinase assay
anaplastic lymphoma
lymphoma kinase
Prior art date
Application number
DK03005186T
Other languages
English (en)
Inventor
Lorenzo A Pinna
Arianna Donella-Deana
Oriano Marin
Luca Mologni
Rosalind Gunby
Passerini Carlo Gambacorti
Leonardo Scapozza
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Application granted granted Critical
Publication of DK1454992T3 publication Critical patent/DK1454992T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03005186T 2003-03-07 2003-03-07 Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf DK1454992T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03005186A EP1454992B1 (en) 2003-03-07 2003-03-07 Anaplastic lymphoma kinase assay, reagents and compositions thereof

Publications (1)

Publication Number Publication Date
DK1454992T3 true DK1454992T3 (da) 2006-10-02

Family

ID=32798804

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03005186T DK1454992T3 (da) 2003-03-07 2003-03-07 Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf

Country Status (14)

Country Link
US (1) US20070031907A1 (da)
EP (1) EP1454992B1 (da)
JP (1) JP2006519800A (da)
CN (1) CN100345978C (da)
AT (1) ATE328112T1 (da)
CA (1) CA2518094A1 (da)
CY (1) CY1106115T1 (da)
DE (1) DE60305634T2 (da)
DK (1) DK1454992T3 (da)
ES (1) ES2263862T3 (da)
IL (1) IL170669A0 (da)
PT (1) PT1454992E (da)
SI (1) SI1454992T1 (da)
WO (1) WO2004079326A2 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2447359B1 (en) 2006-04-14 2015-11-04 Cell Signaling Technology, Inc. Gene defects and mutant ALK kinase in human solid tumors
US8168383B2 (en) 2006-04-14 2012-05-01 Cell Signaling Technology, Inc. Gene defects and mutant ALK kinase in human solid tumors
EP2107054A1 (en) 2008-04-01 2009-10-07 Università Degli Studi Di Milano - Bicocca Antiproliferative compounds and therapeutic uses thereof
CA2722326A1 (en) 2008-04-24 2009-10-29 Incyte Corporation Macrocyclic compounds and their use as kinase inhibitors
EP2161271A1 (en) 2008-09-08 2010-03-10 Università Degli Studi Di Milano - Bicocca Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl
US8765727B2 (en) 2009-01-23 2014-07-01 Incyte Corporation Macrocyclic compounds and their use as kinase inhibitors
ES2668775T3 (es) * 2009-06-10 2018-05-22 Chugai Seiyaku Kabushiki Kaisha Compuestos tetracíclicos
CN101955995B (zh) * 2010-06-17 2013-06-26 江苏迈迪基因生物科技有限公司 淋巴瘤相关的融合基因的诊断试剂盒
US20120101108A1 (en) 2010-08-06 2012-04-26 Cell Signaling Technology, Inc. Anaplastic Lymphoma Kinase In Kidney Cancer
MX355836B (es) 2010-08-20 2018-05-02 Chugai Pharmaceutical Co Ltd Composicion que comprende compuestos tetraciclicos.
EP2847353B1 (en) 2012-05-10 2022-01-19 The General Hospital Corporation Methods for determining a nucleotide sequence
US10668075B2 (en) 2012-09-25 2020-06-02 Chugai Seiyaku Kabushiki Kaisha RET inhibitor
KR20150118159A (ko) 2013-02-22 2015-10-21 에프. 호프만-라 로슈 아게 암의 치료 방법 및 약물 내성의 예방 방법
JP7016215B2 (ja) 2014-01-27 2022-02-04 ザ ジェネラル ホスピタル コーポレイション 配列決定のために核酸を調製する方法
EP3135671B1 (en) 2014-04-25 2019-09-18 Chugai Seiyaku Kabushiki Kaisha Novel crystal of tetracyclic compound
WO2015163448A1 (ja) 2014-04-25 2015-10-29 中外製薬株式会社 4環性化合物を高用量含有する製剤
TWI831347B (zh) 2014-08-08 2024-02-01 日商中外製藥股份有限公司 包含4環性化合物的非晶質體之固體分散體及製劑
JP6741596B2 (ja) 2015-01-16 2020-08-19 中外製薬株式会社 併用医薬
JP6997773B2 (ja) 2016-09-15 2022-01-18 アーチャーディーエックス, エルエルシー 無細胞dnaの分析用の核酸サンプル調製の方法
CA3037185A1 (en) 2016-09-15 2018-03-22 ArcherDX, Inc. Methods of nucleic acid sample preparation
CN110191959B (zh) 2016-11-02 2024-04-09 阿谢尔德克斯有限责任公司 用于免疫组库测序的核酸样品制备方法
CN112384223B (zh) 2018-06-29 2024-08-27 中外制药株式会社 含有难溶性碱性药剂的药物组合物
WO2020050241A1 (ja) 2018-09-04 2020-03-12 中外製薬株式会社 4環性化合物の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05126833A (ja) * 1991-10-31 1993-05-21 Tosoh Corp チロシンキナ−ゼ活性の免疫化学的測定法及びそのキツト
CA2117913C (en) * 1992-04-10 2006-05-09 Richard J. Epstein Activation-state-specific phosphoprotein immunodetection
ES2136103T3 (es) * 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.
GB9314271D0 (en) * 1993-07-09 1993-08-18 Inst Of Cancer The Research Cell growth factor receptors
US6001621A (en) * 1993-11-23 1999-12-14 Genetech, Inc. Protein tyrosine kinases
JP3442784B2 (ja) * 1993-11-23 2003-09-02 ジェネンテク,インコーポレイテッド キナーゼ受容体活性化検定法
US5529925A (en) * 1993-12-03 1996-06-25 St. Jude Children's Research Hospital Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
US5763198A (en) * 1994-07-22 1998-06-09 Sugen, Inc. Screening assays for compounds
US5759787A (en) * 1996-08-26 1998-06-02 Tularik Inc. Kinase assay
WO1998049317A2 (en) * 1997-04-28 1998-11-05 Sugen, Inc. Diagnosis and treatment of phosphatase- 0r kinase-related disorders
US6806266B1 (en) * 1999-07-13 2004-10-19 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives

Also Published As

Publication number Publication date
WO2004079326A2 (en) 2004-09-16
US20070031907A1 (en) 2007-02-08
CA2518094A1 (en) 2004-09-16
CY1106115T1 (el) 2011-06-08
PT1454992E (pt) 2006-09-29
WO2004079326A3 (en) 2004-12-09
DE60305634T2 (de) 2006-09-21
EP1454992B1 (en) 2006-05-31
IL170669A0 (en) 2011-08-01
DE60305634D1 (de) 2006-07-06
CN100345978C (zh) 2007-10-31
SI1454992T1 (sl) 2006-10-31
ATE328112T1 (de) 2006-06-15
CN1756850A (zh) 2006-04-05
EP1454992A1 (en) 2004-09-08
HK1068154A1 (en) 2005-04-22
ES2263862T3 (es) 2006-12-16
JP2006519800A (ja) 2006-08-31

Similar Documents

Publication Publication Date Title
PT1454992E (pt) Ensaio de quinase do linfoma anaplastico, reagentes e composicoes
WO2005111212A3 (en) Biological bar code
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
WO2005028443A3 (en) Protein tyrosine kinase enzyme inhibitors
DK1766412T3 (da) Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner
DE60007095D1 (de) Calanolide zur hemmung von btk
WO2005012574A3 (en) Biological bar-code
DK1706424T3 (da) FC-region varianter
ATE330038T1 (de) Nukleinsäure-biosensor
EA200501563A1 (ru) Пролекарства ингибиторов киназы pi-3
DE602004018780D1 (de) Inhibitoren von thienopyridin- und furopyridinkinase
DK1847611T3 (da) Rhamnose-inducerbart ekspressionssystem
EP1700120A4 (en) MARKER FOR OPTICAL NEUROMYELITIS
WO2002047535A3 (en) High throughput assay to detect inhibitors of the map kinase pathway
ATE413884T1 (de) Beta-secretase-substrat und seine verwendung
WO2004050842A3 (en) Atm kinase compositions and methods
ATE494548T1 (de) Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase
DE60117591D1 (de) Verfahren zum nachweis von serine/threonine kinase aktivität
DE50309381D1 (de) Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen
NO20033921L (no) Inhibitor av monoaminopptak
WO2004084708A3 (en) Finding usable portion of sigmoid curve
ATE457317T1 (de) Chemokine rezeptor
DE60207833D1 (de) Peptiddeformylase-hemmer
EP1559721A4 (en) NEW FPRL1 LIGANDS AND THEIR USE
ATE430317T1 (de) Enzymatische messung von imatinib-mesylat